Monocyte activation in rheumatoid arthritis: Evidence for in situ activation and differentiation in joints
Ridley MG, Kingsley G, Pitzalis C, Panayi GS. Monocyte activation in rheumatoid arthritis: Evidence for in situ activation and differentiation in joints. Br J Rheumatol. 1990;29:84-8.
IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type 2 collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation
Joosten LA, Helsen MM, Saxne T, et al. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type 2 collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation. J Immunol. 1999;163:5049-55.
Randomised double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha(ca2) versus placebo in rheumatoid arthritis
Eliott MJ, Maini RN, Feldmann M, et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha(ca2) versus placebo in rheumatoid arthritis. Lancet. 1994;344:1105-10.
Bliddal H, Terslev L, Ovistgaard E, Kristoffersen H, Torp-Pedersen S, Danneskiold-Samsoe B. Injection of etanercept into arthritic joints. 1. Safety. Ann Rheum Dis. 2002;61(Suppl 1):169.
Injection of etanercept into arthritic joints. 2. Dose-response and efficacy
Bliddal H, Ovistgaard E, Terslev L, Savnik A, Holm CC, Kristoffersen H, et al. Injection of etanercept into arthritic joints. 2. Dose-response and efficacy. Ann Rheum Dis. 2002;61(Suppl 1):38.
Fat-cell changes as a mechanism of avascular necrosis of the femoral head in cortisone-treated rabbits
Wang GJ, Sweet DE, Reger SI, Thompson RC. Fat-cell changes as a mechanism of avascular necrosis of the femoral head in cortisone-treated rabbits. J Bone Joint Surg Am. 1977;59:729-35.